Asset Details
Do you wish to reserve the book?
Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2
Do you wish to request the book?
Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2
1998
Overview
Brown et al report a novel plasmid-mediated carbapenemase (ARI-2) from a multiresistant clinical isolate of Acinetobacter baumannii from Argentina.
Publisher
Elsevier Ltd,Lancet,Elsevier Limited
Subject
/ Acinetobacter Infections - drug therapy
/ Antibiotics. Antiinfectious agents. Antiparasitic agents
/ Bacteria
/ beta-Lactamases - isolation & purification
/ beta-Lactamases - pharmacology
/ Biological and medical sciences
/ Humans
/ Metalloproteins - isolation & purification
/ Metalloproteins - pharmacology
/ Pharmacology. Drug treatments
/ Plasmids
